chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a licensed practical nurse concerning an 8 year old female patient who on 17-JAN-2001, was vaccinated with the first dose of VARIVAX (MERCK).  On 10-APR-2007, was vaccinated with the second dose of VARIVAX (Merck) (lot # 656289/1510F), 0.5 ml subcutaneously.  The nurse reported that the patient "recently" in July 2008, developed breakthrough of chickenpox; she was diagnosed while vacationing out of state.  The breakthrough was considered to be moderate with no fever.  The patient recovered within 7 days of the onset date.  The patient sought unspecified medical attention.  No further information is available.  The patient's brother also had an adverse experience after vaccination with VARIVAX (Merck) (WAES # 0807USA02223).
Pt c/o (L) arm pain. Unable to raise arm x 4 days. Pt notified doc office on 10/20/14 of reaction. Pt stated able to raise arm enough to put on deodorant today.
patient reported feeling malaise and low grade fever starting about 4-5 hours after being given the vaccination. The fever escalated up to 105 F. Leading the patient to go to the Medical Center ER on 07/19/2019. Patient was told  by medical stafff at the hospital that is was likely due to the vaccine. According to the patient IV fluids were administered, but no medication was given. The patient stayed for observation for less than 1 day.
Nausea followed by syncope and 2 minutes of unconsciousness before leaving the office; followed by persistent nausea, dizziness and fatigue, which resulted in her staying in the exam room for 1 hr. She had recurrent symptoms 8/16 PM, and 8/17 AM, resulting in eval at the ER.  In ER, she was noted to be hypotensive during the episode, with BP in the 70s/40s.
headache; body ache; fever; Chills; This is a spontaneous report from a contactable consumer. A 63-year-old female patient received second dose of BNT162B2 (BNT162B2) via an unspecified route of administration, administered in Arm Left on 18Feb2021 (Batch/Lot Number: EL3247) as SINGLE DOSE for covid-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient received initial  dose of BNT162B2 on 28Jan2021 (Lot number=EL3247, Administration time=09:45 A.M, Administrator route=Intramuscular at Left arm). The patient experienced Headache, body ache, fever and chills on 18Feb2021 at 21:00. The patient underwent lab tests and procedures which included body temperature: 101 on 18Feb2021. The outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
The second dose was scheduled through an email from the vaccinating healthcare system. Upon arrival, the vaccine being administered that day was the first dose of a different vaccine, despite the fact that the patient had confirmed three times that it was the second dose of the Pfizer vaccine. The second dose vaccination process had already been delayed by a late scheduling email and has now been further delayed due to an administration problem on the vaccinating party side.
I started with severe headaches; I had body aches, chills and no fever. Increased heart rate with minimal exertion. Increased blood pressure. And I had weight loss because I couldn't eat for loss of appetite. It lasted for three weeks. I lost 7 lbs. The headaches were extreme - had to get a shot of Toradol to block the headaches. I had a Telemed appt with one of the nurse practitioners on Jan 25th. I went in to the Dr's office because headache still wasn't cleared the day before my second vaccine which was on February 8 and that's when I got the Toradol shot.  The next day, (Feb 9) I had my second vaccine and I didn't have any reaction from it.  I ended up with Ulcer symptoms because I took too much Tylenol from the headache - so labs were taken for that on February 9th.
Developed some late-stage type asthma/1st it was exercise asthma/in the last year she developed asthma; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 05Oct2022 as dose 5 (booster), single (Lot number: GH9693) at the age of 68 years for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (ongoing), notes: Osteoporosis: takes Prolia 60mg subcutaneous injection twice a year. diagnosed 7 years ago.; "little bit of arthritis" (ongoing), notes: Gets injections like gel in knee as needed, not steroid/cortisone; got 1st  injection in Oct2022; "left branch bundle blockage" (unspecified if ongoing), notes: L branch bundle blockage had all her life. takes no medication for this and there is no treatment.; "Asthma" (ongoing); "post traumatic stress syndrome" (ongoing); "Panic attacks for no reason. Suffers greatly for anxiety" (ongoing), notes: genetic predisposition to general anxiety. Concomitant medication(s) included: ALBUTEROL [SALBUTAMOL] taken for asthma (ongoing); PROLIA subcutaneous taken for osteoporosis; XANAX taken for post-traumatic stress disorder, anxiety, start date: 2004. Vaccination history included: BNT162b2 (Dose: 01, Lot: ER2613), administration date: 19Mar2021, when the patient was 67-year-old, for COVID-19 Immunization, reaction(s): "1st one she felt a little foggy and maybe just a little tired", "1st one she felt a little foggy and maybe just a little tired"; BNT162b2 (Dose: 02, Lot: EW0153), administration date: 09Apr2021, when the patient was 67-year-old, for COVID-19 Immunization, reaction(s): "2nd one a lot more fatigued"; BNT162b2 (Dose: 03, Lot: FH8020), administration date: 19Oct2021, when the patient was 67-year-old, for COVID-19 Immunization, reaction(s): "3rd one in October was very similar to 1st one/1st one she felt a little foggy and maybe just a little tired", "3rd one in October was very similar to 1st one/1st one she felt a little foggy and maybe just a little tired"; BNT162b2 (Dose: 04, Lot: FK9894), administration date: 08Apr2022, when the patient was 68-year-old, for COVID-19 Immunization, reaction(s): "Went to outdoor wedding in last September and got pneumonia from kids running around", "Then had more, the 4th in Apr2022. A little fatigued and a little soreness at site", "Then had more, the 4th in Apr2022. A little fatigued and a little soreness at site". The following information was reported: ASTHMA (non-serious), outcome "unknown", described as "Developed some late-stage type asthma/1st it was exercise asthma/in the last year she developed asthma". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: Developed some late-stage type asthma. 1st it was exercise asthma. In the last year she developed asthma. No one in the family has asthma. Her Achillies heal was asthma.
Chills, nausea, rapid heartrate, dizziness, injection site pain. No relief of symptoms yet.
diagnosed to have Covid; unable to sleep; This spontaneous case was reported by a patient and describes the occurrence of INSOMNIA (unable to sleep) and COVID-19 (diagnosed to have Covid) in a 73-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     The patient had no allergies to medications, food and other products.  The patient's past medical history included Asthma (just childhood asthma which already resolved).    On 24-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Oct-2022, the patient experienced INSOMNIA (unable to sleep). On 31-Oct-2022, the patient experienced COVID-19 (diagnosed to have Covid). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency; DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) ongoing since an unknown date at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE (ZYRTEC DUO) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, INSOMNIA (unable to sleep) and COVID-19 (diagnosed to have Covid) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Oct-2022, SARS-CoV-2 test: (Positive) went to the physician and was diagnosed to have Covid..         In Apr-2021, the patient received first dose of Moderna COVID-19 vaccine.  In May-2021, the patient received second dose of Moderna COVID-19 vaccine.  In Oct-2021, the patient received third/first booster dose of Moderna COVID-19 vaccine.  On 24-Oct-2022, the patient received fourth/second booster dose of Moderna COVID-19 vaccine.  On 28-Oct-2022, the patient did not feel well.  On 29-Oct-2022, the patient felt worse.  On 30-Oct-2022, the patient had sore throat, cough and could not sleep. She was sick as a dog.  On 31-Oct-2022, she went to the physician and was diagnosed to have Covid. She was prescribed with Mucinex.  At the time of the call, the patient states that the patient was not getting better and felt to be beaten to death. She was still unable to sleep and was congested (as the patient was only able to sleep for 2-3 hours), and hence felt tired and exhausted. The patient had diarrhea in the morning of 18-Nov-2022.  The patient reported that she understands that she was old but it had been 3-4 weeks and she should be getting better. The symptoms had worsened.
Felt crummy; Had hives; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt crummy) and URTICARIA (Had hives) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included ORAL CONTRACEPTIVE NOS, MULTIVITAMIN [ASCORBIC ACID;CALCIUM PANTOTHENATE;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE] and FISH OIL for an unknown indication.    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt crummy) and URTICARIA (Had hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, MALAISE (Felt crummy) and URTICARIA (Had hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-382252 (Patient Link).
CHRONIC FATIGUE; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (CHRONIC FATIGUE) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FATIGUE (CHRONIC FATIGUE). At the time of the report, FATIGUE (CHRONIC FATIGUE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received and patient gender updated to female, reporter's mail added, DOB of patient added, date of vaccine added
DOSE #3 PFIZER COVID VACCINE GIVEN 10/10/21, LOT # UNKNOWN; pt resides in a Nursing and Rehab Center locally; brough to hospital ( locally) via EMS after blood work drawn at facility the day prior, and BUN > 100; while en route to hospital, the pt's BP dropped requiring a NS bolus with improvement; admitted ; tested positive for COVID; treating providers:   MD and APN,FNP; pt dc'd to SNF where she later passed away
2 or 3 days after the vaccine, my left foot became inflamed in a gout like condition; Swollen from toe to bottom of calf; Missed 3 nights sleep; Had to walk with a cane for two weeks.; Swollen from toe to bottom of calf. Very painful; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (2 or 3 days after the vaccine, my left foot became inflamed in a gout like condition), PERIPHERAL SWELLING (Swollen from toe to bottom of calf), INSOMNIA (Missed 3 nights sleep), GAIT DISTURBANCE (Had to walk with a cane for two weeks.) and PAIN IN EXTREMITY (Swollen from toe to bottom of calf. Very painful) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLAMMATION (2 or 3 days after the vaccine, my left foot became inflamed in a gout like condition), PERIPHERAL SWELLING (Swollen from toe to bottom of calf), INSOMNIA (Missed 3 nights sleep), GAIT DISTURBANCE (Had to walk with a cane for two weeks.) and PAIN IN EXTREMITY (Swollen from toe to bottom of calf. Very painful). At the time of the report, INFLAMMATION (2 or 3 days after the vaccine, my left foot became inflamed in a gout like condition), PERIPHERAL SWELLING (Swollen from toe to bottom of calf), INSOMNIA (Missed 3 nights sleep), GAIT DISTURBANCE (Had to walk with a cane for two weeks.) and PAIN IN EXTREMITY (Swollen from toe to bottom of calf. Very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment medications provided.
This spontaneous report received from a patient via a company representative concerned an 80 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced sore arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm was not reported. This report was non-serious.
Awoke with red itchy rash on anterioposterior torso, upper inner arms, neck groin, all apparent in a.m. given prednisone and medrol dose pak to follow prednisone dosing, zyrtec.
Horrible leg cramp; it's the calf and it's under my knee in the back, like 7 or 8 times I was in agony/Horrible leg cramps (i have never had them before and constant trips to the bathroom; Fever/temperature i know of; My throat, it feels like it's completely swollen and glands are like they are swollen; Massive headache; Dizziness; My throat, it feels like it's completely swollen and glands are like they are swollen; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9267), via an unspecified route of administration on 26Feb2021 at 12:00 (at the age of 66-year-old), as dose 1, single in left arm for COVID-19 immunization. The patients medical history included Crohns disease and she was immunosuppressed. The patients past drug included Augmentin and experienced allergies. Concomitant medications included mercaptopurine (PURINETHOL, 50 mg); bupropion hydrochloride (WELLBUTRIN); Famotidine; Omeprazole; pregabalin (LYRICA); Buspirone; Venlafaxine; Glycopyrrolate; Infliximab (REMICADE, 2 mg) received every 7 weeks; and Denosumab (PROLIA) received twice a year; all taken for unspecified indications; start and stop dates were not reported. On 26Feb2021 at 15:00, 15 hours after the first dose of vaccine, the patient experienced a horrible leg cramp; it was the calf and it was under her knee in the back, like 7 or 8 times she was in agony, with fever, throat, it felt like it was completely swollen and glands are like they are swollen, massive headache and dizziness. Patient had Crohns but she reported that this was not Crohns, for which she was going to bathroom and this was completely different. Fever stopped immediately; it was 101.7 at 9 morning. Patient had more symptoms in her throat, it felt like it was completely swollen, and glands are like they are swollen. Patient received treatment with Tylenol. The patient underwent lab test and procedure which included body temperature: 101.7 at 09:00 AM, on an unspecified date in Feb2021. The clinical outcome of fever was resolved. The clinical outcome of all other events was unknown. No follow-up attempts are needed. No further information is expected.
starts having pain-left arm / radiates down to left arm; pain starts at injection site-left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (starts having pain-left arm / radiates down to left arm) and VACCINATION SITE PAIN (pain starts at injection site-left arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 029A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (starts having pain-left arm / radiates down to left arm) and VACCINATION SITE PAIN (pain starts at injection site-left arm). At the time of the report, PAIN IN EXTREMITY (starts having pain-left arm / radiates down to left arm) and VACCINATION SITE PAIN (pain starts at injection site-left arm) had not resolved.            Concomitant product use was not provided by the reporter.  No treatment information was provided.
On 10/26/2022, I had symptoms in the morning, extreme difficulty breathing in the evening and tested positive for COVID-19.  I started Paxlovid. I tested negative on November 18, 2022. On January 18, 2023, I had an Ocular Migraine. I saw my doctor. It broke up my vision on the right side. Migraine symptoms last 10 days .  They would come back at night.
This spontaneous case, initially received on 12-Oct-2018, reported by other non-healthcare professional, concerning a 07-year-old, female child patient. The patient's current condition included metal sensitivities. On an unspecified date in Oct-2017 (reported as late Oct-2017), the patient was administered influenza vaccine (dose, frequency, route of administration, anatomical location, batch number, trade name, manufacturer and expiry date: not reported). Within 24 hours after vaccination, the patient developed reactions at the injection site with red welts for 1-3 weeks. On an unspecified date after vaccination, the patient experienced fever and aching all over, for a couple of weeks (reported as 1-3 weeks), as a reaction to the vaccine. According to the patient's primary care physician (PCP), the reactions were either due to the mercury or the sorbitol contained in the vaccine and the reporter thought that it was due to the preservatives in the multidose vial (MDV) (related). At the time of this report, the patient had recovered from injection site reactions. The outcome of the events fever and generalised aching lasted for 1-3 weeks and then resolved. The reporter considered the events as related (side effects) to the suspect vaccine. This case is linked to the case 201804491 owing to the same reporter. Follow-up received on 02-Nov-2018 from other non-health professional: Age of the patient was added in the patient tab. Current condition 'metal sensitivity' was added under other relevant history in patient tab. Vaccination date 'Oct-2017' was added in the product tab. Events 'injection site reaction', 'injection site erythema' and 'injection site urticaria' was added in the event tab. Narrative and case comment was amended accordingly. Follow-up received from the reporter on 15-Nov-2018: The verbatim 'body aches' was added to the event 'generalized aching'. The outcome of the events generalised aching and fever was updated from 'not reported' to 'resolved'. The narrative was amended accordingly.
Modern a COVID 19 vaccine EUA No initial reaction to shot other than slight soreness.  On the 6th day following the shot I noticed an itchy red rash and some swelling around the injection site which eventually spread to the front of my upper arm.  The next night I went to the ER to have it checked and was told about Moderna Arm.  I began taking Benedryl tablets and the rash and itching seem to be going away.
w/in 15min of vax devel swelling & erythema @ inj site;15 mins later wheals scattered over body to ER;
Pt recv vax on 8/27/98; on 08/28/98 pt exp swelling/ red/ pain at vax site, fever (103F), myalgia
Site: Pain at Injection Site-Mild, Systemic: mouth sores-Medium, Additional Details: Mouth sores occured day after vaccine and patient was unsure of the cause, suspects it was vaccine.
The day following vaccine in left arm patient (37 y/o female family physician) developed raised erythematous painful lesions left neck and supraclavicular region as well as upper back.  Not clearly vesicular but questionable shingles, did not seek treatment but more lesions did appear in following week.
At an unspecified time in 1999, the pt received his first injection with Lymerix. A few days later, he experienced a fever and "fluish symptoms", which resolved in 3-4 days. The pt received the second dose of Lymerix at an unspecified time and a few days later had the same symptoms. Also, he experienced joint pain. These symptoms worsened, and the pt had an MRI and nerve conduction testing, the results were not provided. The syptoms were treated with a muscle relaxant, and an anti-inflammatory and a pain medication.  The information received on 3/20/00 reports the joint pain is ongoing.
Case number PHEH2013US008352 is an initial spontaneous report received from a nurse on 10 Apr 2013. This report refers to an 18-years-old female patient whose medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M102006, expiry date: Oct 2014) at a dose of 0.5 ml intramuscularly on 21 Mar 2013. It was reported that the vaccine had been at 33 to 36 F for 19 days and it was not frozen. No adverse events were reported following the administration error.
Case completed primary Covid vaccine series in March 221, then was hospitalized for and died of Covid in October 2021.  Patient was a lovely 80 year old female with a history of CLL, atrial fibrillation, and COPD who was admitted with acute hypoxic respiratory failure due to covid-19 pneumonia. She had tested positive on 9/30 and had been prescribed dexamethasone as an outpatient. That was continued on admission. After admission she had increasing supplemental oxygen needs despite the steroid. ID was consulted. Her CRP was increasing so she was started on high dose methylprednisolone. A repeat covid test had a cycle threshold of 22 suggesting active viral replication, so she was started on remdesivir. She was also started on baricitinib. Despite these interventions Patient had increasing oxygen requirements. She ultimately elected to transition to comfort care on the evening of 10/10. She died peacefully with her family by her side on the afternoon of 10/11/21.